Compton C, Compton C (2020) Cancer initiation, promotion, and progression and the acquisition of key behavioral traits. Cancer: The Enemy from Within. Springer
Boubertakh B, Silvestri C, Di Marzo V (2022) Obesity: the fat tissue disease version of cancer. Cells 11(12):1872
Article CAS PubMed PubMed Central Google Scholar
Mattiuzzi C, Lippi G (2019) Current cancer epidemiology. J Epidemiol Glob Health 9(4):217
Article PubMed PubMed Central Google Scholar
Loeffen EA, Knops RR, Boerhof J, Feijen EL, Merks JH, Reedijk AM et al (2019) Treatment-related mortality in children with cancer: prevalence and risk factors. European J Cancer 121:113–122
Miller KD, Nogueira L, Devasia T, Mariotto AB, Yabroff KR, Jemal A et al (2022) Cancer treatment and survivorship statistics, 2022. CA Cancer J Clin 72(5):409–436
Miller KD, Nogueira L, Mariotto AB, Rowland JH, Yabroff KR, Alfano CM et al (2019) Cancer treatment and survivorship statistics, 2019. CA Cancer J Clin 69(5):363–385
Jin S, Sun Y, Liang X, Gu X, Ning J, Xu Y et al (2022) Emerging new therapeutic antibody derivatives for cancer treatment. Signal Transduct Target Ther 7(1):39
Article CAS PubMed PubMed Central Google Scholar
Miao X, Yang W, Feng T, Lin J, Huang P (2018) Drug nanocrystals for cancer therapy. Wiley Interdiscip Rev Nanomed Nanobiotechnology 10(3):e1499
Navya P, Kaphle A, Srinivas S, Bhargava SK, Rotello VM, Daima HK (2019) Current trends and challenges in cancer management and therapy using designer nanomaterials. Nano Convergence 6(1):1–30
Joseph E, Singhvi G (2019) Multifunctional nanocrystals for cancer therapy: a potential nanocarrier. Nanomater Drug Deliv Ther 91–116
Desai N, Momin M, Khan T, Gharat S, Ningthoujam RS, Omri A (2021) Metallic nanoparticles as drug delivery system for the treatment of cancer. J Expert Opinion Drug Deliv 18(9):1261–1290
Yenurkar D, Nayak M, Mukherjee S (2023) Recent advances of Nanocrystals in Cancer theranostics. Nanoscale Adv
Lu L, Xu Q, Wang J, Wu S, Luo Z, Lu L (2022) Drug nanocrystals for active tumor-targeted drug delivery. Pharmaceutics 14(4):797
Article CAS PubMed PubMed Central Google Scholar
Sharma OP, Patel V, Mehta T (2016) Nanocrystal for ocular drug delivery: hope or hype. Drug Deliv Transl Res 6:399–413
Peltonen L, Hirvonen J (2018) Drug nanocrystals–versatile option for formulation of poorly soluble materials. Int J Pharm 537(1–2):73–83
Article CAS PubMed Google Scholar
Al-Kassas R, Bansal M, Shaw J (2017) Nanosizing techniques for improving bioavailability of drugs. J Control Release 260:202–212
Article CAS PubMed Google Scholar
Fontana F, Figueiredo P, Zhang P, Hirvonen JT, Liu D, Santos HA (2018) Production of pure drug nanocrystals and nano co-crystals by confinement methods. Adv Drug Deliv Rev 131:3–21
Article CAS PubMed Google Scholar
Sharma OP, Patel V, Mehta T (2016) Design of experiment approach in development of febuxostat nanocrystal: application of Soluplus® as stabilizer. Powder Technol 302:396–405
Patel V, Sharma OP, Mehta T (2018) Nanocrystal: a novel approach to overcome skin barriers for improved topical drug delivery. Expert Opin Drug Deliv 15(4):351–368
Sinha B, Müller RH, Möschwitzer JP (2013) Bottom-up approaches for preparing drug nanocrystals: formulations and factors affecting particle size. Int J Pharm 453(1):126–141
Article CAS PubMed Google Scholar
Malamatari M, Taylor KM, Malamataris S, Douroumis D, Kachrimanis K (2018) Pharmaceutical nanocrystals: production by wet milling and applications. Drug Discov Today 23(3):534–547
Article CAS PubMed Google Scholar
Mohammad IS, Hu H, Yin L, He W (2019) Drug nanocrystals: Fabrication methods and promising therapeutic applications. Int J Pharm 562:187–202
Article CAS PubMed Google Scholar
Patel V, Sharma OP, Mehta TA (2019) Impact of process parameters on particle size involved in media milling technique used for preparing clotrimazole nanocrystals for the management of cutaneous candidiasis. AAPS PharmSciTech 20:1–15
Chogale M, Gite S, Patravale V (2020) Comparison of media milling and microfluidization methods for engineering of nanocrystals: a case study. Drug Dev Ind Pharm 46(11):1763–1775
Article CAS PubMed Google Scholar
Junyaprasert VB, Morakul B (2015) Nanocrystals for enhancement of oral bioavailability of poorly water-soluble drugs. Asian J Pharm Sci 10(1):13–23
Parveen N, Abourehab MA, Thanikachalam PV, Khar RK, Kesharwani P (2023) Nanocrystals as an emerging nanocarrier for the management of dermatological diseases. Colloids and Surf B Biointerf. 113231
Romero GB, Keck CM, Müller RH (2016) Simple low-cost miniaturization approach for pharmaceutical nanocrystals production. Int J Pharm 501(1–2):236–244
Article CAS PubMed Google Scholar
Pawar VK, Singh Y, Meher JG, Gupta S, Chourasia MK (2014) Engineered nanocrystal technology: in-vivo fate, targeting and applications in drug delivery. J Control Release 183:51–66
Article CAS PubMed Google Scholar
Jarvis M, Krishnan V, Mitragotri S (2019) Nanocrystals: a perspective on translational research and clinical studies. Bioeng Transl Med 4(1):5–16
Shojaeiarani J, Bajwa D, Holt G (2020) Sonication amplitude and processing time influence the cellulose nanocrystals morphology and dispersion. Nanocomposites 6(1):41–46
Sohn JS, Yoon DS, Sohn JY, Park JS, Choi JS (2017) Development and evaluation of targeting ligands surface modified paclitaxel nanocrystals. Mater Sci Eng C 72:228–237
Asimakidou T, Makridis A, Veintemillas-Verdaguer S, Morales M, Kellartzis I, Mitrakas M et al (2020) Continuous production of magnetic iron oxide nanocrystals by oxidative precipitation. Chem Eng J 393:124593
Shah PS, Husain S, Johnston KP, Korgel BA (2001) Nanocrystal arrested precipitation in supercritical carbon dioxide. J Phys Chem B 105(39):9433–9440
Padrela L, Rodrigues MA, Duarte A, Dias AM, Braga ME, de Sousa HC (2018) Supercritical carbon dioxide-based technologies for the production of drug nanoparticles/nanocrystals–a comprehensive review. Adv Drug Deliv Rev 131:22–78
Article CAS PubMed Google Scholar
Aymonier C, Philippot G, Erriguible A, Marre S (2018) Playing with chemistry in supercritical solvents and the associated technologies for advanced materials by design. J Supercritic Fluids 134:184–196
Huang X, Shi Q, Du S, Lu Y, Han N (2021) Poly-tannic acid coated paclitaxel nanocrystals for combinational photothermal-chemotherapy. Colloids Surf B 197:111377
Salazar J, Ghanem A, Müller RH, Möschwitzer JP (2012) Nanocrystals: comparison of the size reduction effectiveness of a novel combinative method with conventional top-down approaches. European J Pharm Biopharm 81(1):82–90
Trivedi V, Ajiboye AL (2023) Supercritical fluids: a promising technique in pharmaceutics. Nano-and microfabrication techniques in drug delivery: recent developments and future prospects. Springer, p 295–320
Kalaydina RV, Bajwa K, Qorri B, Decarlo A, Szewczuk MR (2018) Recent advances in “smart” delivery systems for extended drug release in cancer therapy. Int J Nanomed. 4727–4745
Lu Y, Lv Y, Li T (2019) Hybrid drug nanocrystals. Adv Drug Deliv Rev 143:115–133
Article CAS PubMed Google Scholar
Bae KH, Chung HJ, Park TG (2011) Nanomaterials for cancer therapy and imaging. Mol Cells 31:295–302
Article CAS PubMed PubMed Central Google Scholar
Kumari P, Ghosh B, Biswas S (2016) Nanocarriers for cancer-targeted drug delivery. J Drug Targeting 24(3):179–191
Xiang H, Xu S, Li J, Li Y, Xue X, Liu Y, et al (2022) Functional drug nanocrystals for cancer-target delivery. J Drug Deliv Sci Technol 103807
Morales-Cruz M, Delgado Y, Castillo B, Figueroa CM, Molina AM, Torres A, et al (2019) Smart targeting to improve cancer therapeutics. Drug Des Develop Therapy. 3753–3772
Kumar M, Jha A, Dr M, Mishra B (2020) Targeted drug nanocrystals for pulmonary delivery: a potential strategy for lung cancer therapy. Expert Opin Drug Deliv 17(10):1459–1472
Article CAS PubMed Google Scholar
Ren X, Qi J, Wu W, Yin Z, Li T, Lu Y (2019) Development of carrier-free nanocrystals of poorly water-soluble drugs by exploring metastable zone of nucleation. Acta Pharm Sinica B 9(1):118–127
Luo Z, Lu L, Xu W, Meng N, Wu S, Zhou J et al (2022) In vivo self-assembled drug nanocrystals for metastatic breast cancer all-stage targeted therapy. J Control Release 346:32–42
Comments (0)